Physician profile
Janet Collier
NPI 1982606695
$3,537.99
in general payments reported to CMS, 2019-2025
15 companies · $574 in 2025
The $574 reported for 2025 was more than what 80% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $415 · 2020: $133 · 2021: $496 · 2022: $390 · 2023: $932 · 2024: $598 · 2025: $574.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,105.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,104.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $827.11 | 2022-2025 | Infuse, Miebo, Xiidra |
| Alcon Vision LLC | $696.84 | 2019-2025 | Tryptyr, Total30, Precision 1 |
| Abbvie INC. | $419.73 | 2022-2025 | Durysta, Vuity, Lumigan |
| Kala Pharmaceuticals, INC. | $219.15 | 2021 | |
| Coopervision INC. | $212.42 | 2019-2024 | Cvi Contact Lens |
| Sun Pharmaceutical Industries INC. | $196.42 | 2019-2024 | Cequa, Xelpros |
| Allergan, INC. | $180.59 | 2019-2022 | |
| Tarsus Pharmaceuticals, INC. | $179.83 | 2024-2025 | Xdemvy |
| Oyster Point Pharma, INC. | $148.80 | 2022-2024 | Tyrvaya |
| Mallinckrodt Hospital Products INC. | $134.06 | 2023-2024 | Acthar |
| Dompe US, INC. | $124.99 | 2024 | Oxervate |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $92.33 | 2019-2021 | |
| Astellas Pharma US INC | $49.00 | 2024-2025 | Izervay |
| Novartis Pharmaceuticals Corporation | $30.44 | 2020-2022 | |
| Thea Pharma INC. | $26.28 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janet Collier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.